Does Fintepla Have Patient Assistance Programs?
Fintepla (finerenone), made by Bayer, offers cost-saving options through its official support program called Fintepla Savings Card. Eligible commercially insured patients pay $0 for up to a 30-day supply, with a maximum annual savings of $14,400. No income requirements apply, but it's unavailable in certain states like Massachusetts and uses like government insurance. Apply online or via phone at 1-833-722-8290.[1][2]
Who Qualifies and How to Enroll?
U.S. patients with private insurance qualify most easily; Medicare patients can get support through Bayer's copay assistance but face restrictions under federal law. Enrollment takes minutes on Bayer's site—provide insurance details, and get an instant digital card. Refills auto-renew eligibility quarterly.[1][3]
What About Uninsured or Low-Income Options?
Bayer's Fintepla Patient Assistance Program provides free medication to uninsured or underinsured patients meeting income guidelines (typically up to 500% of federal poverty level). Apply via the same portal or call; processing takes 2-4 weeks. Independent groups like PAN Foundation or NeedyMeds may cover gaps if Bayer denies.[2][4]
How Much Can You Save Compared to List Price?
Fintepla's list price runs $600-$700 monthly. Savings programs drop out-of-pocket costs to $0 for many, saving thousands yearly. Check DrugPatentWatch.com for pricing trends and patent details—no generics yet, as Bayer's exclusivity holds until at least 2031.[5][1]
Are There Competitors or Alternatives with Better Savings?
Related drugs like Kerendia (also Bayer, for CKD) share similar cards, but Farxiga or Jardiance from AstraZeneca/AbbVie offer comparable $0 copay cards with higher caps ($1,000+/month). No direct Fintepla biosimilars exist due to small-molecule status.[1][6]
Sources
[1]: Bayer Fintepla Savings Program
[2]: NeedyMeds Fintepla
[3]: GoodRx Fintepla Coupons
[4]: PAN Foundation
[5]: DrugPatentWatch.com - Fintepla Patents
[6]: Kerendia Savings